What pairs well - and what doesn't

Across five separate disease areas, omega-3 alone did little while omega-3 added to an active treatment worked. The combinations below are graded from the same trial record.

Pairs well

Statins

Every positive heart trial ran on a statin base - and statins chemically prime the enzymes that turn omega-3 into resolution signals. An adjunct, never a statin substitute.

B vitamins, for the brain

In one trial, B vitamins slowed brain shrinkage in mild cognitive impairment only when omega-3 status was adequate. Each gates the other - check status before a B-vitamin protocol.

A lower-omega-6 diet

The cheapest amplifier there is: in a migraine trial, cutting omega-6 while raising omega-3 doubled the benefit versus raising omega-3 alone. Less competition for the same enzymes.

Exercise and weight loss

In metabolic and liver studies, omega-3 only moved the needle when stacked on diet, exercise, or weight loss. Lifestyle is the engine; omega-3 is a bolt-on.

Neutral

Vitamin D

A 25,000-person factorial trial settled it: effects are additive, not synergistic. Fine together - just don't buy the “synergy” marketing.

Use caution

Aspirin

Mechanistically the most exciting pairing - aspirin redirects an enzyme toward special resolution molecules. But at 4 g/day EPA it also stacks two blood-thinning effects, and the combination has never been outcome-tested.

Alcohol, in fatty liver

Alcohol drives liver injury through the very pathways omega-3 is meant to help - it actively works against the therapy. Address it first.

Fat-absorption blockers

Orlistat, bile-acid binders, and possibly ezetimibe can blunt absorption. Separate the doses and verify with a blood test.

High-dose vitamin E

Above 400 IU/day it carries its own bleeding and mortality signals - a stacked risk next to high-dose EPA. Capsule-stabilizer amounts are fine.